Latest News

A selection of recent news and views from Catapult Ventures follows...

UKI2S, Catapult Ventures and Jonathan Milner invest £500k in Gene Modulation Newcomer Pencil Biosciences

11th December, 2019, Alderley Park: UK Innovation & Science Seed Fund (UKI2S), Catapult Ventures’ GM&C Life Sciences Fund and Jonathan Milner are pleased to announced an investment in Pencil Biosciences...

AMRC - Dr Peter Jackson article in Laboratory News

Moving from Push to Pull Nothing less than an entirely new model of drug development is needed if we are to create new antibiotics says Dr Peter Jackson. And it’s something NICE are finally taking seriously as they set about developing a ne...

AMR Centre - World Antibiotic Awareness Week

This week is World Antibiotic Awareness Week. Watch the video produced by the AMR Centre here:  

AMR Centre candidate targets superbugs with problem metallo-β-lactamase enzymes

Alderley Park, UK, 11 November 2019   The AMR Centre has nominated a preclinical candidate in its program that tackles drug resistance conferred by NDM-1 and other metallo-β-lactamases (MBL).  The MBL inhibitor (MBLI) research...

Nexus Labs selected for prestigious Accelerator Programme at Alderley Park

We are delighted to share that Nexus Labs has been selected for the prestigious Accelerator Programme at Alderley Park, powered by BioCity. represented by CEO Glyn Estebanez, Nexus will be one of 7 high-potential life-sciences start-ups...

From our portfolio

Arlabion

Biotechnology

Arlabion is an agri-tech company developing a novel seed treatment to protect crops against funga...

viewview our portfolio

Our Team

Rob Carroll

view complete team

Contact us

Binder House
7 Narborough Wood Park
Desford Road
Enderby
Leicester
LE19 4XT

Tel: 0116 238 8200

email